Tissue | Expression Dynamics | Abbreviation |
Colorectum (GSE201348) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Becker/KCNQ1_pca_on_diff_genes.png) | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Chen/KCNQ1_pca_on_diff_genes.png) | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/KCNQ1_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/KCNQ1_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00060063 | Colorectum | FAP | glucose metabolic process | 48/2622 | 196/18723 | 5.90e-05 | 1.16e-03 | 48 |
GO:00059963 | Colorectum | FAP | monosaccharide metabolic process | 59/2622 | 257/18723 | 6.79e-05 | 1.28e-03 | 59 |
GO:00860012 | Colorectum | FAP | cardiac muscle cell action potential | 24/2622 | 76/18723 | 6.86e-05 | 1.29e-03 | 24 |
GO:00902574 | Colorectum | FAP | regulation of muscle system process | 58/2622 | 252/18723 | 7.22e-05 | 1.33e-03 | 58 |
GO:0035725 | Colorectum | FAP | sodium ion transmembrane transport | 44/2622 | 178/18723 | 9.31e-05 | 1.60e-03 | 44 |
GO:0023061 | Colorectum | FAP | signal release | 94/2622 | 463/18723 | 1.06e-04 | 1.76e-03 | 94 |
GO:00702521 | Colorectum | FAP | actin-mediated cell contraction | 28/2622 | 97/18723 | 1.06e-04 | 1.76e-03 | 28 |
GO:00228981 | Colorectum | FAP | regulation of transmembrane transporter activity | 62/2622 | 278/18723 | 1.09e-04 | 1.80e-03 | 62 |
GO:00324121 | Colorectum | FAP | regulation of ion transmembrane transporter activity | 60/2622 | 267/18723 | 1.12e-04 | 1.84e-03 | 60 |
GO:00515911 | Colorectum | FAP | response to cAMP | 27/2622 | 93/18723 | 1.26e-04 | 2.03e-03 | 27 |
GO:00324092 | Colorectum | FAP | regulation of transporter activity | 67/2622 | 310/18723 | 1.59e-04 | 2.43e-03 | 67 |
GO:0010959 | Colorectum | FAP | regulation of metal ion transport | 83/2622 | 406/18723 | 2.06e-04 | 2.96e-03 | 83 |
GO:00068691 | Colorectum | FAP | lipid transport | 81/2622 | 398/18723 | 2.84e-04 | 3.76e-03 | 81 |
GO:00860031 | Colorectum | FAP | cardiac muscle cell contraction | 22/2622 | 73/18723 | 2.88e-04 | 3.77e-03 | 22 |
GO:0001508 | Colorectum | FAP | action potential | 34/2622 | 134/18723 | 3.30e-04 | 4.22e-03 | 34 |
GO:0006814 | Colorectum | FAP | sodium ion transport | 54/2622 | 245/18723 | 3.98e-04 | 4.85e-03 | 54 |
GO:0046683 | Colorectum | FAP | response to organophosphorus | 33/2622 | 131/18723 | 4.61e-04 | 5.39e-03 | 33 |
GO:00030122 | Colorectum | FAP | muscle system process | 89/2622 | 452/18723 | 4.63e-04 | 5.39e-03 | 89 |
GO:00713202 | Colorectum | FAP | cellular response to cAMP | 17/2622 | 53/18723 | 6.20e-04 | 6.82e-03 | 17 |
GO:0043270 | Colorectum | FAP | positive regulation of ion transport | 58/2622 | 275/18723 | 7.98e-04 | 8.36e-03 | 58 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KCNQ1 | SNV | Missense_Mutation | rs199472704 | c.626C>T | p.Ser209Phe | p.S209F | P51787 | protein_coding | deleterious(0) | probably_damaging(0.932) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
KCNQ1 | SNV | Missense_Mutation | | c.653N>T | p.Lys218Met | p.K218M | P51787 | protein_coding | deleterious(0) | probably_damaging(0.92) | TCGA-A2-A04P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | PD |
KCNQ1 | SNV | Missense_Mutation | rs749351255 | c.553G>A | p.Val185Met | p.V185M | P51787 | protein_coding | tolerated(0.13) | possibly_damaging(0.539) | TCGA-A7-A26H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | PD |
KCNQ1 | SNV | Missense_Mutation | | c.1440N>A | p.Met480Ile | p.M480I | P51787 | protein_coding | tolerated(0.38) | benign(0) | TCGA-D8-A1XJ-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | tamoxiphen | SD |
KCNQ1 | insertion | In_Frame_Ins | novel | c.1461_1462insATTTTA | p.Glu487_Asp488insIleLeu | p.E487_D488insIL | P51787 | protein_coding | | | TCGA-A2-A0CQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
KCNQ1 | insertion | Frame_Shift_Ins | novel | c.1462_1463insATTTTTTTTCAGTAAGTTTGTATGTAGT | p.Leu489PhefsTer36 | p.L489Ffs*36 | P51787 | protein_coding | | | TCGA-A2-A0CQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
KCNQ1 | deletion | Frame_Shift_Del | rs776103376 | c.1258delN | p.Lys422SerfsTer10 | p.K422Sfs*10 | P51787 | protein_coding | | | TCGA-EW-A1IZ-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD |
KCNQ1 | SNV | Missense_Mutation | rs199472692 | c.484N>A | p.Val162Met | p.V162M | P51787 | protein_coding | deleterious(0) | probably_damaging(0.976) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
KCNQ1 | SNV | Missense_Mutation | | c.1278N>G | p.Asp426Glu | p.D426E | P51787 | protein_coding | tolerated(0.52) | benign(0.005) | TCGA-JX-A3PZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
KCNQ1 | SNV | Missense_Mutation | | c.1895N>A | p.Arg632Lys | p.R632K | P51787 | protein_coding | tolerated(0.62) | benign(0.036) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | | INDAPAMIDE | INDAPAMIDE | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | blocker | 135650484 | | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | activator | 135650906 | | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | | Indapamide | INDAPAMIDE | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | blocker | 252166811 | | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | | INSULIN | INSULIN | 17182020 |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | blocker | 53801037 | | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | | BEPRIDIL | BEPRIDIL | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | | ICA-105665 | | |
3784 | KCNQ1 | DRUGGABLE GENOME, ION CHANNEL, CELL SURFACE | blocker | 135650352 | CHEMBL298475 | |